Population Based Study of Long-Term Rates of Surgery for Urinary Incontinence After Radical Prostatectomy for Prostate Cancer

2012 ◽  
Vol 188 (2) ◽  
pp. 502-506 ◽  
Author(s):  
Robert K. Nam ◽  
Sender Herschorn ◽  
D. Andrew Loblaw ◽  
Ying Liu ◽  
Laurence H. Klotz ◽  
...  
Blood ◽  
2011 ◽  
Vol 117 (5) ◽  
pp. 1707-1709 ◽  
Author(s):  
Vittorio Pengo ◽  
Franco Noventa ◽  
Gentian Denas ◽  
Martino F. Pengo ◽  
Umberto Gallo ◽  
...  

Abstract Whether long-term use of vitamin K antagonists (VKAs) might affect the incidence of cancer is a longstanding hypothesis. We conducted a population-based study including all cancer- and thromboembolism-free patients of our health area; study groups were defined according to chronic anticoagulant use to VKA-exposed and control groups. Cancer incidence and cancer-related and overall mortality was assessed in both groups. 76 008 patients (3231 VKA-exposed and 72 777 control subjects) were followed-up for 8.2 (± 3.2) years. After adjusting for age, sex, and time-to-event, the hazard ratio of newly diagnosed cancer in the exposed group was 0.88 (95% confidence interval [95% CI] 0.80-0.98; P < .015). VKA-exposed patients were less likely to develop prostate cancer, 0.69 (95% CI 0.50-0.97; P = .008). The adjusted hazard ratio for cancer-related and overall mortality was 1.07 (95% CI 0.92-1.24) and 1.12 (95% CI 1.05-1.19), respectively. These results support the hypothesis that anticoagulation might have a protective effect on cancer development, especially prostate cancer.


2017 ◽  
Vol 117 (2) ◽  
pp. 321-327 ◽  
Author(s):  
Eugenio Ventimiglia ◽  
Yasin Folkvaljon ◽  
Stefan Carlsson ◽  
Ola Bratt ◽  
Francesco Montorsi ◽  
...  

2013 ◽  
Vol 113 (4) ◽  
pp. 541-547 ◽  
Author(s):  
Martin Andreas Røder ◽  
Klaus Brasso ◽  
Ib Jarle Christensen ◽  
Jørgen Johansen ◽  
Niels Christian Langkilde ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e16553-e16553
Author(s):  
Grace L. Lu-Yao ◽  
Jianming He ◽  
Veda N. Giri ◽  
Ann Klassen

e16553 Background: This population-based study assesses the relationship between insurance status and patterns of prostate cancer diagnosis and treatment among men under age 65. Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified 114,871 prostate cancer patients who were diagnosed before 65 between January 2007 and December 2013. Insurance type was classified as uninsured (3.1%), Medicaid (5.1%) and other including private insurance and coverage from the military or Veterans Affairs (91.8%). We used logistic regression model to quantify the relative risk of being diagnosed with metastasis or regional disease, and the relative likelihood of receiving radical prostatectomy or radiotherapy among those with localized cancer adjusted by, age, race, marital status, region, and diagnosis period. Results: Medicaid or uninsured patients are more likely to have late diagnosis (diagnosed with positive lymph node or metastasis) than patients with non-Medicaid insurance (Table 1). Among men diagnosed with localized prostate cancer, Medicaid and uninsured patients are less likely to receive prostatectomy. Medicaid patients are more likely to have radiotherapy than un-insured (see table). Conclusions: Compared with patients with non-Medicaid insurance, Medicaid and uninsured patients are more likely have late diagnosis and less likely to have radical prostatectomy for localized cancer, after accounting for differences in age, race, marital status, region, and diagnosis period. [Table: see text]


Author(s):  
Floortje Mols ◽  
Ida J. Korfage ◽  
Ad J.J.M. Vingerhoets ◽  
Paul J.M. Kil ◽  
Jan Willem W. Coebergh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document